PREFERRED STOCK EXCHANGE AGREEMENTPreferred Stock Exchange Agreement • February 22nd, 2017 • Sevion Therapeutics, Inc. • Services-commercial physical & biological research • Delaware
This PREFERRED STOCK EXCHANGE AGREEMENT (this “Agreement”) is dated as of February 15, 2017, by and between Sevion Therapeutics, Inc., a Delaware corporation (the “Company”), and the holder listed on the signature page hereto (the “Holder”).
CONSENT AND WAIVER AGREEMENTConsent and Waiver Agreement • February 22nd, 2017 • Sevion Therapeutics, Inc. • Services-commercial physical & biological research • New York
This Consent and Waiver Agreement (this “Agreement”) is made effective as of February 15, 2017 (the “Effective Date”) by and among Sevion Therapeutics, Inc., a Delaware corporation (the “Company”), the lead investor in the 2015 Financing (as defined below) (the “Lead Investor”), and the undersigned signatories hereto.
